Subcutaneous allergen-specific immunotherapy versus topical treatment in vernal keratoconjunctivitis

Cornea

Volumn 31, Issue 5, 2012, Pages 525-528

  Rahman Mahdy, Reda Abdel ^a   Nada, Waled M ^a   Marei, Ayman A ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

subcutaneous allergen specific immunotherapy (SCIT); topical; vernal keratoconjunctivitis

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CROMOGLYCATE DISODIUM; FLUOROMETHOLONE; IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; SCHOOL CHILD; SKIN MANIFESTATION; VERNAL CONJUNCTIVITIS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ALLERGENS; CHILD; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; INJECTIONS, INTRADERMAL; MALE; PROSPECTIVE STUDIES; SKIN TESTS; YOUNG ADULT;

EID: 84859951638     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181eae270     Document Type: Article

References (17)

1. Ortega ZB, Vargas RMA, Tsuchiya IFM, et al. Allergic conjunctivitis in children. Rev Alerg Mex. 2007;54:41-53.
2. Foster CS. Randomized clinical trial of topically administered cromolyn sodium in vernal keratoconjunctivitis. Am J Ophthalmol. 1980;90:175.
3. Niederberger V. Allergen-specific immunotherapy. Immunol Lett. 2009; 122:131-134.
4. Frew AJ, Powell RL, Christopher CL, et al. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment of resistant allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;9:65-69.
5. Noon L. Prophylactic inoculation against hayfever. Lancet. 1911;1:1572-1573.
6. Bousquet J, Lockery R, Malling HJ. Allergen immunotherapy: therapeutic vaccine for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102:558-562.
7. Ronalland JL, Gardner LM, O'Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol Ther. 2009;121:273-284.
8. Werfel T. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy? J Allergy Clin Immunol. 2009;124: 1003-1004.
9. Burastero SE, Mistrello G, Paolucci C, et al. Clinical and immunological correlates of pre-co-seasonal sublingual immunotherapy with birch monomeric allergoid in patients with allergic rhinoconjunctivitis. Int J Immunopathol Pharmacol. 2009;22:343-352.
10. Malling HJ, Montagut A, Melac M, et al. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis. Clin Exp Allergy. 2009;39: 387-393.
11. Aghayan-Ugurluoglu RA, Ball T, Vrtala S, et al. Dissociation of allergenspecific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol. 2000;105:803.
12. Satwani H, Rehman A, Ashraf S, et al. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc. 2009;59: 698-702.
13. Joint Task Force On Practice Parameters. Allergen immunotherapy: a practice parameters second update. J Allergy Clin Immunol. 2007;120: S25-S85.
14. Prakash OM, Murthy KR. Imm-unotherapy in allergic conjunctivitis. Indian J Ophthalmol. 1992;40:9-10.
15. Mimura T, Yamagami S, Amano S, et al. Allergens in Japanese patients with allergic conjunctivitis in autumn. Eye. 2005;19:995-1001.
16. Bulawa E, Borysewicz G, Markiewicz K. Efficacy of specific immunotherapy in children with seasonal allergic rhinitis and conjunctivitis, sensitized to grass pollen [Polish]. Med Wieku Rozwoj 2001;5:351-358.
17. Wahn U, Taber A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2009;123:160-166.